QuintilesIMS Real-World Insights Bibliography

Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).
Author(s): Amouretti M, Le Pen C, Gaudin AF, Bommelaer G, Frexinos F, Ruszniewski P, Poynard T, Maurel F, Priol G, El Hasnaoui A.
Affiliations(s): 
Publication(s): Gastroenterol Clin Biol. 2006 Feb;30(2):241-6.
Document Type(s): Manuscript in preparation
Countries: France
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
Quality of life
  Add to report
 
 
Prevalence and dietetic management dietético of slight gastrointestinal diseases in breast-fed baby: EDEN Study.
Author(s): Infante D, Badia X, Ariño B, Villegas V.
Affiliations(s): 
Publication(s): 
Document Type(s): In press/to be published
Countries: Spain
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
  Add to report
 
 
Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Author(s): Balboa A, Mearin F, Badía X, Benavent J, Caballero A, Domínguez-Muñoz JE, et al.
Affiliations(s): 
Publication(s): Eur J Gastroenterol Hepatol 2006;18(12):1271-7
Document Type(s): Manuscript in preparation
Countries: Spain
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
Quality of life
  Add to report
 
 
[Documento de consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal] Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease.
Author(s): Cabriada JL1, Doménech E2, Gomollón F3, González-Carro P4, González-Lara V5, Hinojosa J6, Jiménez-López CE7, Nos P8, Obrador A9, Panès J10, Saro C11, Varea V12, Lafuente R13, Guilera M14.
Affiliations(s): 1 Hospital de Galdakao. Galdakao. Vizcaya. España. 2 Hospital Germans Trias i Pujol. Badalona. Barcelona. España. 3 Hospital Lozano Blesa. Zaragoza. España. 4 Hospital La Mancha Centro. Alcázar de San Juan. Ciudad Real. España. 5 Hospital Gregorio Marañón. Madrid. España. 6 Hospital de Sagunto. Sagunto. Valencia. España. 7 Hospital Virgen del Camino. Pamplona. Navarra. España. 8 Hospital La Fe. Valencia. España. 9 Hospital Son Dureta. Palma de Mallorca. Baleares. España. 10 Hospital Clínic. Barcelona. España. 11 Hospital de Cabueñes. Gijón. Asturias. España. 12 Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España. 13 Hospital Creu Roja. L’Hospitalet de Llobregat. Barcelona. España. 14 HOR-Europe. Barcelona. España.
Publication(s): Gastroenterol Hepatol. 2006;29(2):85-92
Document Type(s): Manuscript in preparation
Countries: Spain
Click here for the abstract
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
Spanish
Methodology
  Add to report
 
 
Infliximab Drug and Infusion Costs Among Patients with Crohn's Disease IN a Commercially-Insured Setting.
Author(s): Ollendorf DA, Lidsky L.
Affiliations(s): 
Publication(s): American Journal OF Therapeutics 2006;13:502-506.
Document Type(s): Manuscript in preparation
Countries: USA
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
  Add to report
 
 
The Current and Future Burden and Cost of Overactive Bladder in Five European Countries.
Author(s): Reeves P1, Irwin D2, Kelleher C3, Milsom I4, Kopp Z5, Calvert N1, Lloyd A1.
Affiliations(s): 1 Fourth Hurdle Consulting, London, UK 2 Dept of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC,US 3 Dept of Obstetrics and Gynaecology, Guy's and St Thomas' NHS Trust, London, UK 4 Dept of Obstetrics and Gynecology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden 5 Pfizer Inc., New York, US
Publication(s): European Urology 2006; 50(5): 1050-1057
Document Type(s): Manuscript in preparation
Countries: Germany, Italy, Spain, Sweden, UK
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
Cost of illness
  Add to report
 
 
Clinical Practice Guideline for irritable bowel syndrome
Author(s): Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J
Affiliations(s): 
Publication(s): Gastroenterol Hepatol. 2006;29(8):467-521
Document Type(s): Article
Countries: Spain
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
Spanish
Methodology
  Add to report
 
 
Infliximab Drug and Infusion Costs Among Patients with Crohn’s Disease in a Commercially-Insured Setting.
Author(s): Ollendorf D, Lidsky L
Affiliations(s): 
Publication(s): American Journal of Therapeutics, 2006, 13(6): 502-506
Document Type(s): Article
Countries: USA
C:
Y:
Gastrointestinal disorders
2006
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
First Page Previous Page  9 of 9